Walgreen Co (WAG)

81.65
1.64 2.05
NASDAQ : Services
Prev Close 80.01
Open 79.90
Day Low/High 79.64 / 81.83
52 Wk Low/High 57.75 / 80.79
Volume 6.62M
Avg Volume 5.56M
Exchange NASDAQ
Shares Outstanding 950.39M
Market Cap 71.90B
EPS 2.03
P/E Ratio 36.74
Div & Yield 1.35 (1.80%)
Pharmacy Sales Help Walgreens, Rite Aid Overcome Delayed Easter

Pharmacy Sales Help Walgreens, Rite Aid Overcome Delayed Easter

The largest and third-largest drugstore chains reported a drop in front-end sales which were offset by an increase in pharmacy and prescription drug income.

How Walgreens (WAG) Performed in March

How Walgreens (WAG) Performed in March

Walgreens (WAG) saw total sales over March increase as pharmacy sales jumped, though the results were offset by weakness in front-end sales.

Walgreens March Sales Increase 4.5 Percent

Walgreens March Sales Increase 4.5 Percent

Walgreens (NYSE: WAG) (Nasdaq: WAG) had March sales of $6.43 billion, an increase of 4.

Walgreen Still Healthy Despite Missing Earnings Again

Walgreen Still Healthy Despite Missing Earnings Again

Walgreen is still profitable despite showing little top-line growth.

3 Stocks Pulling The Services Sector Downward

3 Stocks Pulling The Services Sector Downward

TheStreet highlights 3 stocks pushing the services sector lower today.

14 Companies With Volatile Rides After Earnings

14 Companies With Volatile Rides After Earnings

Five Below, Steelcase and Lululemon are the biggest winners after posting earnings while Cache, Blackberry and Red Hat are the biggest losers.

Walgreen Company (WAG): Today's Featured Retail Winner

Walgreen Company (WAG): Today's Featured Retail Winner

Walgreen Company was a winner within the retail industry, rising $1.01 (1.6%) to $65.36 on light volume

Is Walgreens Giving Shareholders a 'Well Experience'?

Is Walgreens Giving Shareholders a 'Well Experience'?

Walgreens' good results in Europe masked problems with its Well Experience makeover. Can services drive drug profits?

Shares of Walgreen Shake Off Quarterly Profit Miss

Shares of Walgreen Shake Off Quarterly Profit Miss

Shares of Walgreen are rising on Wednesday despite reporting second-quarter earnings that missed expectations. The drugstore chain said profit was hurt by price cuts it made in order to compete with rivals during the holiday season. Walgreen said a slowdown of generic drug introduction and a mild flu season also weighed on the company's results. However, CEO Greg Wasson said pressure from fewer new generic drugs on the market would lighten in the second half of the fiscal year.

Shares of Walgreen Climb Despite Profit Missing Expectations

Shares of Walgreen Climb Despite Profit Missing Expectations

Shares of Walgreen are rising despite the drugstore chain saying it was hurt by price cuts it made in order to compete with rivals during the holiday season.

Dow Closes Higher on Positive Housing Data

Dow Closes Higher on Positive Housing Data

Stock markets gain Tuesday amid the release of housing data that underscored the ongoing economic recovery despite being slightly below expectations.

2 Big Stocks Getting Big Earnings Attention

2 Big Stocks Getting Big Earnings Attention

Here's how to trade two of Wall Street's most active stocks following their earnings reports.

Jim Cramer's Mad Dash: WAG CSX

Jim Cramer's Mad Dash: WAG CSX

Walgreen is great and CSX is a cheap railroad compared with its peers, Cramer says.

Walgreen (WAG) Rises Despite Earnings Miss

Walgreen (WAG) Rises Despite Earnings Miss

Walgreen (WAG) rose on Tuesday despite its second-quarter earnings report that came up short of analysts' expectations. A slowdown in generic drug introduction and a mild flu season hampered the largest U.S. drugstore chain's performance. Walgreen reported a year-over-year decline in net income to $754 million, or 78 cents a share, from $756 million, or 79 cents a share. Profit excluding items was 91 cents, two cents less than the consensus estimate of analysts polled by Thomson Reuters. Walgreen said price cuts it made to compete with rivals during the difficult holiday season also put pressure on its second-quarter profit. Gross profit margin declined 1.3% year over year to 28.8%. Sales rose 5.1% to $19.61 billion, while comparable-store sales in stores open at least a year rose 4.3% thanks mostly to prescription sales gains, which generate almost two-thirds of the company's revenue. Comparable-store sales of general merchandise ticked upward just 2% thanks to fewer shoppers entering Walgreen's drugstores. CEO Greg Wasson said the pressure from fewer new generic drugs would lighten in the second half of the fiscal year. The company also said its partnership with Alliance Boots Holdings, which runs the largest European pharmacy chain, could generate synergies between $375 million and $425 million, up $25 million from its previous estimate. Walgreen wants to combine the companies' drug purchases and sell the European products in its stores. Walgreen bought 45% of Alliance Boots in 2012 with an option to buy the remainder in 2015.

March 25 Premarket Briefing: 10 Things You Should Know

March 25 Premarket Briefing: 10 Things You Should Know

U.S. stock futures rise; Disney buys Maker Studios; Box files for its IPO; King Digital, the maker of 'Candy Crush,' is expected to begin trading on Wednesday; Luxottica to make frames for Google Glass.

Walgreen Company (WAG) Rising Before The Market Opens

Walgreen Company (WAG) Rising Before The Market Opens

Trade-Ideas LLC identified Walgreen Company (WAG) as a pre-market leader candidate

Market Hustle: Stock Futures Rise Ahead of Housing Data; Disney Advances

Market Hustle: Stock Futures Rise Ahead of Housing Data; Disney Advances

U.S. stock futures are edging higher Tuesday as Walt Disney shares rise and investors await a full slate of economic reports, much of it focused on the housing market.

Day Ahead: Consumer Data Dominate

Housing, consumer-confidence reports due; futures rising.

Walgreen Co. Reports Fiscal 2014 Second Quarter Results

Walgreen Co. Reports Fiscal 2014 Second Quarter Results

Walgreen Co. (NYSE: WAG) (Nasdaq: WAG) today announced earnings and sales results for the second quarter and first half of fiscal year 2014 ended Feb.

May 17th Options Now Available For Walgreen (WAG)

May 17th Options Now Available For Walgreen (WAG)

Investors in Walgreen Co. saw new options begin trading today, for the May 17th expiration.

Investing Ahead of Earnings: McCormick, Sonic and Walgreen

Investing Ahead of Earnings: McCormick, Sonic and Walgreen

Cache, Five Below and Steelcase round out today's pre-earnings preview.

Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan

Cramer will be watching earnings from a slew of companies and awaiting China's manufacturing PMI number.

Walgreen Company (WAG): Today's Featured Retail Laggard

Walgreen Company (WAG): Today's Featured Retail Laggard

Walgreen Company was a leading decliner within the retail industry, falling $1.75 (-2.6%) to $64.75 on heavy volume

Cramer: Walgreen's Report Will Tell Us If the Rotation Is Over

Cramer: Walgreen's Report Will Tell Us If the Rotation Is Over

Walgreen reports earnings this week, an item that Jim Cramer says will be key to watch because there's currently a rotation out of higher multiple stocks like Walgreen into lower multiple stocks.

Walgreens Second Quarter 2014 Earnings Release, Conference Call Scheduled For March 25

Walgreens Second Quarter 2014 Earnings Release, Conference Call Scheduled For March 25

Walgreens (NYSE: WAG)(Nasdaq: WAG) will release its fiscal 2014 second quarter earnings results at 7:30 a.

Why Walgreen Acts Like Walmart, Not CVS

Why Walgreen Acts Like Walmart, Not CVS

Walgreen is positioning itself to function like a Walmart -- leveraging its tremendous purchasing power to squeeze profit from its suppliers (drug manufacturers) as well as maximizing efficiencies on the distribution side of the business.

Pre-Market Activity Shows Gains For Walgreen Company (WAG)

Pre-Market Activity Shows Gains For Walgreen Company (WAG)

Trade-Ideas LLC identified Walgreen Company (WAG) as a pre-market leader candidate

Will This Target Price Increase Help Walgreen (WAG) Today? (Update)

Will This Target Price Increase Help Walgreen (WAG) Today? (Update)

UBS increased its target price on Walgreen (WAG) to $90 and set a "buy" rating. The firm cited the company's specialty pharma tax inversion playbook to pharma services as the reason for the move.

Infinity Appoints Two Experienced Life Science Leaders to Its Board of Directors

Infinity Appoints Two Experienced Life Science Leaders to Its Board of Directors

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that it has appointed José Baselga M.

Walgreen Company (WAG): Today's Featured Retail Laggard

Walgreen Company (WAG): Today's Featured Retail Laggard

Walgreen Company was a leading decliner within the retail industry, falling $1.77 (-2.6%) to $66.71 on average volume